REQUEST A DEMO
Total
USD $0.00
Search more companies

Partner-Invest OOO (Serpukhov) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Partner-Invest OOO Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Partner-Invest OOO (Serpukhov) is based in Russia, with the head office in Serpukhov. The enterprise currently operates in the Pharmacies and Drug Stores sector. Partner-Invest OOO (Serpukhov) was incorporated on September 24, 2019. It currently has a total number of 59 (2022) employees. The latest financial highlights indicate a net sales revenue increase of 16.26% in 2023. A growth of 19.42% was recorded in its total assets. In 2023, Partner-Invest OOO (Serpukhov)’s net profit margin increased by 3.65%.

Headquarters
Vodonapornaya, 36-A, 204
Serpukhov; Moscow Oblast; Postal Code: 142200

Contact Details: Purchase the Partner-Invest OOO (Serpukhov) report to view the information.

Website: http://med-celitel.ru

Basic Information
Total Employees:
Purchase the Partner-Invest OOO (Serpukhov) report to view the information.
Outstanding Shares:
Purchase the Partner-Invest OOO (Serpukhov) report to view the information.
Registered Capital:
Purchase the Partner-Invest OOO (Serpukhov) report to view the information.
Incorporation Date:
September 24, 2019
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Partner-Invest OOO (Serpukhov) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
16.26%
Total operating revenue
16.26%
Operating profit (EBIT)
404.14%
Net Profit (Loss) for the Period
3121.48%
Total assets
19.42%
Total equity
23.96%
Operating Profit Margin (ROS)
3.67%
Net Profit Margin
3.65%
Return on Equity (ROE)
18.59%
Quick Ratio
0.76%
Cash Ratio
0.84%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?